Pharma & Biotech

Danaher Corporation faces heightened investor scrutiny as a legal investigation emerges just days before the company's critical third-quarter earnings announcement....

The biotechnology firm Atossa Therapeutics is positioning itself for a significant transition, yet market participants remain divided on its prospects....

Generation Bio shares are experiencing extreme volatility as the biotechnology firm undergoes a dramatic corporate transformation. Facing an existential challenge,...

Novo Nordisk finds itself navigating one of its most challenging periods, as the Danish pharmaceutical giant contends with a rapidly...

The proposed acquisition of CureVac by its larger competitor BioNTech has moved significantly closer to completion following a crucial regulatory...

Shares of Assembly Biosciences experienced a powerful upward movement following the release of compelling clinical trial data for its genital...

Bruker's stock is currently presenting investors with a complex picture. While recent trading sessions have revealed promising short-term recovery signals,...

Amid turbulent equity markets, Thermo Fisher Scientific stands out with notable resilience. This life sciences behemoth isn't just rewarding shareholders...

Replimune Group Inc. finds itself navigating turbulent waters as multiple challenges converge. The biotechnology firm faces substantial headwinds from regulatory...

Investors in Corbus Pharmaceuticals are bracing for a pivotal market catalyst this weekend. The biotechnology firm is scheduled to present...